Effects of dexamethasone on the TGF-β1-induced epithelial-to- mesenchymal transition in human peritoneal mesothelial cells

Laboratory Investigation

Volumn 93, Issue 2, 2013, Pages 194-206

  Jang, Yang Hee ^a   Shin, Hyun Soo ^a   Sun Choi, Hack ^a   Ryu, Eun Sun ^a   Jin Kim, Mi ^a   Ki Min, Seog ^a   Lee, Joo Ho ^a   Kook Lee, Hyeon ^a   Kim, Kwang Ho ^a   Kang, Duk Hee ^a  

^a Ewha Womans University School of Medicine   (South Korea)

Author keywords

dexamethasone; epithelial to mesenchymal transition; human peritoneal mesothelial cells; peritoneal fibrosis; TGF

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR ANTAGONIST; GLYCOGEN SYNTHASE KINASE 3BETA; MIFEPRISTONE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN ZO1; SMAD3 PROTEIN; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN;

ARTICLE; CELL MIGRATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; HUMAN PERITONEAL MESOTHELIAL CELL; MESOTHELIUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

ACTINS; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CADHERINS; DEXAMETHASONE; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MIFEPRISTONE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PERITONEAL FIBROSIS; PERITONEUM; PHOSPHORYLATION; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA1; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84873880140     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2012.166     Document Type: Article

References (43)

1. Aroeira LS, Aguilera A, Sanchez-Tomero JA, et al. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol 2007;18:2004-2013.
2. Yanez-Mo M, Lara-Pezzi E, Selgas R, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. New Engl J Med 2003;348:403-413.
3. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002;2:442-454.
4. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420-1428.
5. Selgas R, Bajo A, Jimenez-Heffernan JA, et al. Epithelial-to-mesenchymal transition of the mesothelial cell-its role in the response of the peritoneum to dialysis. Nephrol Dial Transplant 2006;21(Suppl 2): ii2-ii7.
6. Yu MA, Shin KS, Kim JH, et al. HGF and BMP-7 ameliorate high glucoseinduced epithelial-to-mesenchymal transition of peritoneal mesothelium. J Am Soc Nephrol 2009;20:567-581.
7. Aguilera A, Aroeira LS, Ramirez-Huesca M, et al. Effects of rapamycin on the epithelial-to-mesenchymal transition of human peritoneal mesothelial cells. Int J Artif Organs 2005;28:164-169.
8. Bajo MA, Perez-Lozano ML, Albar-Vizcaino P, et al. Low-GDP peritoneal dialysis fluid ('balance') has less impact in vitro and ex vivo on epithelial-to-mesenchymal transition (EMT) of mesothelial cells than a standard fluid. Nephrol Dial Transplant 2011; 26:282-291.
9. Evans RM. The steroid and thyroid hormone receptor superfamily. Science 1988;240:889-895.
10. Bledsoe RK, Montana VG, Stanley TB, et al. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 2002; 110:93-105.
11. Godoy P, Lakkapamu S, Schug M, et al. Dexamethasone-dependent versus-independent markers of epithelial to mesenchymal transition in primary hepatocytes. Biol Chem 2010;391:73-83.
12. Kimura H, Li X, Torii K, et al. Glucocorticoid enhances hypoxia-and/or transforming growth factor-beta-induced plasminogen activator inhibitor-1 production in human proximal renal tubular cells. Clin Exp Nephrol 2011;15:34-40.
13. Birchmeier W. Cell adhesion and signal transduction in cancer. EMBO Rep 2005;6:413-417.
14. Zhou Binhua P., Deng Jiong, Xia Weiya, et al. Dual regulation of Snail by GSK-3b-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 2004;6:931-940.
15. Witowski J, Jö rres A. Peritoneal cell culture: fibroblasts. Perit Dial Int 2006;26:292-299.
16. Kim SH, Yu MA, Ryu ES, et al. Indoxyl sulfate-induced epithelial-tomesenchymal transition and apoptosis of renal tubular cells as novel mechanisms of progression of renal disease. Lab Invest 2012;92: 488-498.
17. Kolosova I, Nethery D, Kern JA. Role of Smad2/3 and p38 MAP kinase in TGF-b1-induced epithelial-mesenchymal transition of pulmonary epithelial cells. J Cell Physiol 2011;226:1248-1254.
18. Li Y, Zhang J, Fang L, et al. Lefty A attenuates the TGF-beta1-induced epithelial to mesenchymal transition of human renal proximal epithelial tubular cells. Mol Cell Biochem 2010;339:263-270.
19. Vargha R, Endemann M, Kratochwill K, et al. Ex vivo reversal of in vivo transdifferentiation in mesothelial cells grown from peritoneal dialysate effluents. Nephrol Dial Transplant 2006;21: 2943-2947.
20. Aroeira LS, Aguilera A, Selgas R, et al. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor. Am J Kidney Dis 2005;46:938-948.
21. Lee HB, Ha H. Mechanisms of epithelial-mesenchymal transition of peritoneal mesothelial cells during peritoneal dialysis. J Korean Med Sci 2007;22:943-945.
22. Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet 2009;373:1905-1917.
23. Nicolaides NC, Galata Z, Kino T, et al. The human glucocorticoid receptor: molecular basis of biologic function. Steroids 2010;75: 1-12.
24. Guller S, Wozniak R, Kong L, et al. Reduction of extracellular matrix protein expression in human amnion epithelial cells by glucocorticoids: a potential role in preterm rupture of the fetal membranes. J Clin Endocrinol Metab 1995;80:3273-3278.
25. Zhang L, Lei W, Wang X, et al. Glucocorticoid induces mesenchymalto-epithelial transition and inhibits TGF-b1-induced epithelial-tomesenchymal transition and cell migration. FEBS Lett 2010;584: 4646-4654.
26. Courtney AE, Doherty CC. Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure. Kidney Int 2006;69:1094.
27. Lafrance JP, Letourneau I, Ouimet D, et al. Successful treatment of encapsulating peritoneal sclerosis with immunosuppressive therapy. Am J Kidney Dis 2008;51:e7-10.
28. Goulding NJ, Euzger HS, Butt SK, et al. Novel pathways for glucocorticoid effects on neutrophils in chronic inflammation. Inflamm Res 1998;47(Suppl 3):S158-S165.
29. Xu J, Lamouille S, Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res 2009;19:156-172.
30. Margetts PJ, Kolb M, Galt T, et al. Gene transfer of transforming growth factor-beta1 to the rat peritoneum: effects on membrane function. J Am Soc Nephrol 2001;12:2029-2039.
31. Margetts PJ, Bonniaud P, Liu L, et al. Transient overexpression of TGF-b1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol 2005;16:425-436.
32. Patel P, Sekiguchi Y, Oh KH, et al. Smad3-dependent and-independent pathways are involved in peritoneal membrane injury. Kidney Int 2010;77:319-328.
33. Lan HY, Chung AC. Transforming growth factor-b and Smads. Contrib Nephrol 2011;170:75-82.
34. Willis BC, Borok Z. TGF-beta-induced EMT mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 2007;293:525-534.
35. Bolkenius U, Hahn D, Gressner AM, et al. Glucocorticoids decrease the bioavailability of TGF-beta which leads to a reduced TGF-beta signaling in hepatic stellate cells. Biochem Biophys Res Commun 2004;325:1264-1270.
36. Miyazaki Y, Tsukazaki T, Hirota Y, et al. Dexamethasone inhibition of TGF beta-induced cell growth and type II collagen mRNA expression through ERK-integrated AP-1 activity in cultured rat articular chondrocytes. Osteoarthritis Cartilage 2000;8:378-385.
37. Stellato C. Post-transcriptional and nongenomic effects of glucocorticoids. Proc Am Thorac Soc 2004;1:255-263.
38. Kassel O, Sancono A, Kratzschmar J, et al. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J 2001;20:7108-7116.
39. Engelbrecht Y, de Wet H, Horsch K, et al. Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines. Endocrinology 2003;144:412-422.
40. Hafezi-Moghadam A, Simoncini T, Yang E, et al. Acute cardiovascular protective effects of corticosteroids are mediated by nontranscriptional activation of endothelial nitric oxide synthase. Nat Med 2002;8:473-479.
41. Onder TT, Gupta PB, Mani SA, et al. Loss of E-Cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 2008;68:3645-3654.
42. Wendt MK, Taylor MA, Schiemann BJ, et al. Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer. Mol Biol Cell 2011;22:2423-2435.
43. Kimura H, Li X, Torii K, et al. Dexamethasone enhances basal and TNFalpha-stimulated production of PAI-1 via the glucocorticoid receptor regardless of 11beta-hydroxysteroid dehydrogenase 2 status in human proximal renal tubular cells. Nephrol Dial Transplant 2009;24:1759-1765.